Duvelisib to Combat COVID-19

NCT04372602 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Duvelisib
PROCEDURE: Peripheral blood draw
DRUG: Placebo

Sponsor

Washington University School of Medicine

Collaborators

[object Object]